Underutilization of AUD medications is attributed to multiple factors, including few Food and Drug Administration (FDA)approved therapies, limited awareness of these medications, and barriers related to stigma, wrote a team of investigators led by Christian Hendershot, Ph.D., director of clinical research at University of Southern Californias Institute for Addiction Science and associate professor at Bowles Center for Alcohol Studies
This effect was reportedly greater than the results observed when either GHK-Cu or HA was studied independently
However, the SUSTAIN six trial evaluated semaglutide, a GLP-1 analog, in patients with type 2 diabetes and high cardiovascular risk and discovered that semaglutide was associated with a higher incidence of diabetic retinopathy complications compared to placebo, with a hazard ratio (HR) of 1.76, particularly in patients with pre-existing DR ( This seemingly controversial impact of GLP-1RAs on DR may be because most trials focused on microvascular and cardiovascular outcomes rather than DR
Injections typically have higher bioavailability because they deliver the full dose directly into the body, whereas sublingual absorption can vary based on how well the drug is absorbed under the tongue
Warning signs requiring immediate medical attention include severe abdominal pain (especially radiating to the back or right upper quadrant), persistent vomiting preventing oral intake, fever, jaundice, or signs of dehydration